Bronchiectasis

December 1, 2015December 1, 2015

Non-CF Bronchiectasis Study Looks at Airway Clearance Techniques

Bronchiectasis, News

Non-cystic fibrosis bronchiectasis symptoms, such as chronic cough and mucus production, are often managed with the use of airway clearance techniques (ACTs), regardless of clinical status. But the efficacy of such interventions for bronchiectasis ... Read more

November 30, 2015May 12, 2016

Pulmonary Rehabilitation New Focus of NY Care Center

Bronchiectasis, News

Gold Crest Care Center, a Bronx, N.Y.-based rehabilitation center, recently announced the opening of its new Skilled Nursing Pulmonary Rehabilitation Program to treat high-risk pulmonary patients. The facility is one the few with this specialized type of ... Read more

October 28, 2015November 6, 2015

Alitair Presents Updates on Bronchiectasis Treatments at 2015 Cavendish Forum

Bronchiectasis, News

Clinical stage pharmaceutical company Alitair Pharmaceuticals is currently presenting at the ongoing Cavendish Global Health Impact Forum in Cleveland, Ohio, which kicked off Sunday, October 25, and concludes on October 28th. The forum ... Read more

October 13, 2015November 6, 2015

Aradigm Announces Completion of Patient Enrollment for Second Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis

Bronchiectasis, News

Aradigm Corporation, a pharmaceutical company focused on the development and commercialization of drugs for the prevention and treatment of severe respiratory diseases, recently announced the conclusion of patient enrollment in the ... Read more

September 23, 2015November 6, 2015

Aradigm Completes Patient Enrollment For Phase III Trial To Test Novel non-Cystic Fibrosis Bronchiectasis Therapy

Bronchiectasis, News

Aradigm, an emerging pharmaceutical company dedicated to the development and commercialization of drugs to treat a wide range of respiratory ailments, recently announced the completion of patient enrollment for ORBIT (Once-daily ... Read more

September 8, 2015November 6, 2015

New Version of Inhaled Antibiotic for Infections in Bronchiectasis, CF Being Developed

Bronchiectasis, News

Basilea Pharmaceutica Ltd. recently announced the development of an inhaled formulation of a new antibiotic called BAL30072 that may facilitate treatment of patients with cystic fibrosis and bronchiectasis. Cystic fibrosis is ... Read more

August 21, 2015November 6, 2015

Raptor Pharmaceutical Expands Its Rare Disease Portfolio For CF, Bronchiectasis By Acquiring Quinsair

Bronchiectasis, News

Raptor Pharmaceutical Corp. recently announced it has signed an agreement with Tripex Pharmaceuticals in order to acquire Quinsair, which is the first inhaled fluoroquinolone that received approval to manage chronic pulmonary infections caused Pseudomonas ... Read more

July 29, 2015November 6, 2015

Rheumatoid Arthritis-Bronchiectasis Patients Exhibit Increase in Disease Severity

Bronchiectasis, News

In a new study entitled “Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co-existent bronchiectasis” researchers measured key markers of rheumatoid arthritis disease activity and severity in ... Read more

July 7, 2015November 6, 2015

Bronchiectasis Identified as a Potential HTLV-associated Disease

Bronchiectasis, News

In a recent study entitled “High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease,” a team of researchers analyzed whether the human T-lymphotropic virus type-1 (HTLV-1), the agent responsible ... Read more

June 17, 2015November 6, 2015

Bronchiectasis May Lead To a Worse Outcome in Patients With COPD

Bronchiectasis, News

Bronchiectasis is a common condition experienced by people with chronic obstructive pulmonary disease (COPD) that involves the widening of the bronchi, which are the main airways to the lungs. COPD refers to a group of ... Read more